Mounjaro and Hypothyroidism: What UK Patients Should Know (October 2026)

01 · The core answer

Can you take Mounjaro with hypothyroidism?

In most cases, having hypothyroidism does not by itself stop you being assessed for Mounjaro. The list of people who should not take it covers allergy to tirzepatide or its ingredients, pregnancy or trying to conceive, and extra caution for a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy or gallbladder problems. An underactive thyroid is not on that list.¹

That does not mean it is irrelevant. Your prescriber has to see your whole picture: the thyroid condition, the medicine you take for it, and anything else in your history. Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity, and individual results vary.¹

02 · What to decide

The two decisions you are really facing

The first decision is whether weight-loss treatment is appropriate for you at all. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes. It comes as a once-weekly pre-filled KwikPen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Whether you meet the criteria depends on your BMI and weight-related health conditions, not on the thyroid diagnosis alone.

The second decision is how to manage the interaction between your routine and the medicine. The mechanism that helps appetite, slowing how quickly the stomach empties, is the same one that makes it sensible to ask about timing of oral medicines such as thyroid tablets.¹

03 · At a glance

Quick reference table

04 · Next step

What to do next

If you are stable on your thyroid treatment and meet the weight-management criteria, the next step is a free online consultation where you list your thyroid diagnosis and your medicines.

You can also browse our wider weight loss clinic for the full treatment range.

Whatever you choose, treat this page as information rather than a substitute for medical advice. If you have symptoms you cannot explain, or your thyroid control has recently changed, speak to your GP before starting any new treatment.

05 · How Mounjaro works

How Mounjaro works and its link to metabolism

Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes.¹ It is not a thyroid medicine and it does not treat hypothyroidism.

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic). If you are comparing the two, the Wegovy pen is the semaglutide option we supply, and the same thyroid-related questions apply to your prescriber whichever you choose.

Where metabolism comes in

People with an underactive thyroid often ask whether a medicine that works on appetite can help when the thyroid is part of the weight picture.

So the honest framing is this. Mounjaro supports eating less by making you feel fuller sooner. Your thyroid treatment is a separate matter, managed by your GP. The two sit side by side, and the thing that connects them is practical, not metabolic: stomach emptying and the timing of tablets.

How long it stays in the body

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ This matters if you are ever asked to pause treatment, for example before a procedure or if your clinician wants to reassess. The effects on stomach emptying fade gradually rather than switching off on the day of the last injection.

If you want to see what the early months typically look like, our week by week guide walks through the titration period in order. Titration means stepping up the strength gradually, and your prescriber decides the pace based on how you are tolerating treatment.

The takeaway for readers with hypothyroidism is that nothing in the mechanism excludes you, and nothing in it promises a thyroid-specific benefit or harm either. What is left is a careful conversation with a prescriber who has your full medicine list in front of them.

06 · Timing your tablets

Timing your medications: the gastric emptying factor

The most practical issue for anyone on thyroid tablets is gastric emptying. Mounjaro helps regulate appetite and slows how quickly the stomach empties.¹ Tablets taken by mouth pass through the same stomach, so it is reasonable to ask whether the timing of your thyroid medicine needs attention.

There is no specific instruction for levothyroxine timing, so ask your prescriber or pharmacist.

What you can sensibly do

Tell the prescriber reviewing your consultation exactly which thyroid medicine you take and at what time of day. Tell your regular pharmacist too, since they see your whole dispensing record. Ask directly: does my routine need to change now that my stomach will empty more slowly?

Keep taking your thyroid medicine consistently while you wait for that answer. Consistency is a sensible default, and stopping or skipping tablets because of an internet article is not. If your clinician suggests a change, follow their advice.

Why consistency matters

Thyroid tablets are usually taken as a settled daily habit, and your GP interprets blood results against that habit. If the routine changes, the results can change for reasons unrelated to your thyroid itself. That is a good reason to let the clinician who reads your blood tests know when you start any new medicine, including a weight-loss injection.

When symptoms change

If you notice new symptoms after starting Mounjaro, do not assume they come from either the injection or your thyroid. Tell your prescriber. If you suspect a side effect, you can report it through the MHRA Yellow Card scheme.¹⁹ Reporting helps regulators spot patterns that individual patients cannot see.

The rule is simple: disclose, ask, and let the clinician who knows your dose decide on timing.

It is also worth keeping your own simple log of when you take your tablet and when you inject. If anything unexpected happens, you will have a clear record to show your GP or prescriber, which makes the conversation much faster and more useful.

07 · Thyroid safety precaution

The thyroid safety precaution explained

The thyroid warning attached to Mounjaro is not about hypothyroidism.

In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹ As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2 — they will weigh this in your assessment.¹ Routine thyroid monitoring is not required for most people.¹

Is hypothyroidism the same thing?

The conditions named in the precaution are medullary thyroid cancer and MEN 2. An underactive thyroid is not named. The safest approach is simply to disclose everything. Include your hypothyroidism, its cause if you know it, any thyroid surgery, and your family history. Your prescriber can then decide whether anything needs a closer look.

What the rodent finding does and does not mean

It is a laboratory finding in animals, and it is not known whether it applies to people. In human trials, no increase has been shown. It is the reason prescribers ask the family-history question, and it is a good reason to answer that question accurately.

Routine monitoring

Because routine thyroid monitoring is not required for most people on Mounjaro, starting treatment does not by itself mean extra thyroid tests. That is separate from any follow-up you already have for hypothyroidism. Keep your existing arrangements with your GP, and tell them you have started treatment so that they can interpret your results in context.

If you want to read about the reverse question, whether a GLP-1 can contribute to thyroid problems, see our guide on whether Mounjaro can cause an underactive thyroid.

In short: tell your prescriber about thyroid cancer or MEN 2 history, tell them about your hypothyroidism, and let them weigh the whole picture. That is the entire safety loop for the thyroid on this treatment.

08 · Weight loss expectations

Weight loss expectations with an underactive thyroid

Many readers ask whether it is harder to lose weight with hypothyroidism, and whether Mounjaro will work the same way.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.²

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

Reading the numbers honestly

Trial averages do not predict your own result. Treat the figures as the range of what a licensed treatment achieved under trial conditions.

Beyond the scales

In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises. They are why prescribers talk about weight management as health management rather than appearance.

What helps in practice

Because treatment works alongside diet and activity, the habits you build matter.

If energy, mood or weight seem out of step with your treatment, ask your GP whether your thyroid control is worth reviewing.

For a wider look at how medicines for weight loss are discussed alongside thyroid conditions, see our guide on weight loss medication with hypothyroidism.

09 · Who should not take it

Who should not take Mounjaro, and what to tell your prescriber

Mounjaro is not suitable for everyone, and the consultation exists to find out whether it is suitable for you. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation.¹

What to put on your list

For someone with hypothyroidism, the useful disclosures are practical. Name your thyroid condition, name the medicine you take for it, and say when in your day you take it. Mention any other regular medicines, because slowed stomach emptying is relevant to oral tablets generally. Mention any family history of medullary thyroid cancer or MEN 2.

If you take insulin or a sulfonylurea, say so. Watch for low blood sugar (shakiness, sweating, confusion), because your prescriber may need to adjust those medicines.¹ It does not mean they cannot be combined with Mounjaro, only that the doses may need attention.

Eligibility versus suitability

Two separate questions are often muddled. Eligibility is whether your BMI and health conditions fit the licence and, on the NHS, the access criteria. Suitability is whether anything in your history makes treatment unwise. A thyroid diagnosis falls into the second question, and it is not named as a barrier.

How our process handles this

Our consultation is free, with no obligation, and is reviewed by a GPhC-registered prescriber rather than a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. That means disclosing your thyroid condition carries no financial risk.

If you are also considering other options, our page on weight loss injections with hypothyroidism explains the wider category. For pen supply, we offer official LillyDirect supply, meaning genuine KwikPens from Eli Lilly's UK distribution, with all six doses stocked.

Above all, answer the questions honestly. The assessment can only weigh what it is told.

10 · NHS and private routes

Mounjaro on the NHS or privately with hypothyroidism

Many people ask whether hypothyroidism qualifies them for Mounjaro on the NHS. Ask your GP how your circumstances are assessed for NHS access.

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶

Questions people ask about NHS access

Does an underactive thyroid change your place in the queue? Does it stop you being considered? The decision rests with your GP and local service, who can see your records.

Ozempic and other names

A related question is whether hypothyroidism qualifies for Ozempic. Hypothyroidism is not a licensing reason for any GLP-1 medicine. Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and a regulated UK pharmacy will not supply Ozempic for weight loss. Mounjaro is licensed for weight management in adults and for type 2 diabetes, and NHS access to Wegovy runs through specialist weight-management services; ask your GP.

Choosing private treatment

Private treatment suits people who meet the licensed criteria but do not want to wait for a phased rollout. With us, you complete a free online consultation, a GPhC-registered prescriber reviews it, and the medicine is dispensed by our registered pharmacy. Same-day dispatch applies when ordered by 3pm, with free next-day tracked delivery in temperature-controlled packaging.

Ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team are included, and repeat orders re-check suitability. There is no auto-shipping. If your thyroid treatment changes while you are on Mounjaro, that is exactly the sort of update to share at a review.

The comparison between NHS and private is therefore about timing and access rather than safety. The clinical questions, including disclosure of your thyroid condition and medicines, are the same on both routes. Our overview of how Mounjaro compares with other options for hypothyroidism helps you set these routes side by side.

11 · Side effects to watch

Side effects and warning signs to watch for

Serious side effects are uncommon but need urgent attention, and knowing the signs matters whatever your thyroid status. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

Kidneys and liver

Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment. The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys, so keep fluids up and contact your clinical team if you cannot keep fluids down. People with severe impairment need individual prescriber assessment.¹

Mood and mental health

Low mood and tiredness are things people with an underactive thyroid may already recognise, so it helps to know what regulators have concluded about GLP-1 medicines and mood. The EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link between these medicines and suicidal thoughts, and the MHRA keeps this under continuous review.¹⁷

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

That said, any big change in weight, appetite and routine can affect how you feel. Tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.¹⁷

Symptoms that are hard to untangle

Tiredness, digestive upset and appetite changes can have several causes when you have a thyroid condition and are starting a new injection. The sensible approach is to report new or worsening symptoms to your prescriber and your GP, and to avoid adjusting thyroid tablets yourself.

If a symptom is not on the full list in the UK patient leaflet, it is not a listed side effect. That does not mean it should be ignored. Discuss new symptoms with your prescriber, and report suspected side effects via the Yellow Card scheme.¹⁹

Support while you are on treatment

Our team offers side-effect support and ongoing monthly reviews, and you can reach us Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat, or by phone on 0333 207 0413. For anything urgent or severe, get medical help straight away or use emergency services rather than waiting for a pharmacy reply.

12 · Ordering and cost

Ordering Mounjaro and what it costs

If you have discussed things with your GP and want to go ahead privately, ordering is straightforward. The consultation is free, and the price shown is the price paid, with no hidden fees.

First, you complete a free online consultation: a short health questionnaire, with no charge and no obligation. Second, a GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Third, our registered pharmacy dispenses and dispatches the order, on the same day when you order by 3pm. Delivery is free next-day tracked delivery with DPD in discreet, temperature-controlled packaging. Saturday delivery is £14.99.

Payment and support

You can pay by Visa or Mastercard, use Klarna, or choose pay-monthly options. There are no subscriptions. Needles, a sharps bin and injection guidance are included with every order, and the free GLPTrackr companion app helps you track your journey on iOS and Android.

Genuine supply

Counterfeit weight-loss pens are a real risk when medicine is bought from sellers offering to supply without a consultation or prescription. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. You can verify our registration on the GPhC register under 9012878.¹² If you ever suspect a fake product, report it through the Yellow Card scheme.⁷

Whichever route you choose, include your thyroid condition and medicines in the consultation. It costs nothing to disclose, and it lets the prescriber give advice that fits you.